SUPT20H
Basic information
Region (hg38): 13:37009312-37059713
Previous symbols: [ "C13orf19", "FAM48A" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SUPT20H gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 30 | 30 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 30 | 0 | 0 |
Variants in SUPT20H
This is a list of pathogenic ClinVar variants found in the SUPT20H region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-37009728-C-T | not specified | Uncertain significance (Jul 17, 2024) | ||
13-37009778-A-G | not specified | Uncertain significance (Jul 07, 2022) | ||
13-37010595-A-C | not specified | Uncertain significance (Aug 30, 2021) | ||
13-37012263-G-T | not specified | Uncertain significance (Jun 26, 2024) | ||
13-37012290-T-A | not specified | Uncertain significance (Jul 26, 2024) | ||
13-37017252-C-T | not specified | Uncertain significance (Nov 24, 2024) | ||
13-37017297-G-C | not specified | Uncertain significance (May 24, 2023) | ||
13-37021453-T-C | not specified | Uncertain significance (Dec 05, 2024) | ||
13-37021517-C-T | not specified | Uncertain significance (Oct 12, 2022) | ||
13-37022023-A-G | not specified | Uncertain significance (Apr 18, 2023) | ||
13-37022030-T-G | not specified | Uncertain significance (May 15, 2024) | ||
13-37022033-T-A | not specified | Uncertain significance (Jun 29, 2023) | ||
13-37024092-G-T | not specified | Uncertain significance (Jan 26, 2022) | ||
13-37024110-G-A | not specified | Uncertain significance (Aug 12, 2024) | ||
13-37024128-T-C | not specified | Uncertain significance (Dec 20, 2021) | ||
13-37024134-A-G | not specified | Uncertain significance (Oct 25, 2024) | ||
13-37024162-G-T | not specified | Uncertain significance (Aug 23, 2021) | ||
13-37024406-C-G | not specified | Uncertain significance (Sep 08, 2024) | ||
13-37024424-C-T | not specified | Uncertain significance (Mar 04, 2024) | ||
13-37025355-T-G | not specified | Uncertain significance (Aug 21, 2023) | ||
13-37026214-C-T | not specified | Uncertain significance (Sep 25, 2023) | ||
13-37026225-C-A | not specified | Uncertain significance (May 08, 2023) | ||
13-37028172-C-T | not specified | Uncertain significance (May 26, 2024) | ||
13-37028187-T-C | not specified | Uncertain significance (Feb 27, 2023) | ||
13-37028190-C-T | not specified | Uncertain significance (Dec 22, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SUPT20H | protein_coding | protein_coding | ENST00000350612 | 25 | 50402 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.73e-14 | 0.992 | 125690 | 0 | 58 | 125748 | 0.000231 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.18 | 325 | 391 | 0.832 | 0.0000193 | 5031 |
Missense in Polyphen | 53 | 75.86 | 0.69865 | 1021 | ||
Synonymous | 0.651 | 126 | 136 | 0.929 | 0.00000676 | 1479 |
Loss of Function | 2.66 | 30 | 50.3 | 0.596 | 0.00000236 | 631 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000210 | 0.000210 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000381 | 0.000381 |
Finnish | 0.0000465 | 0.0000462 |
European (Non-Finnish) | 0.000321 | 0.000316 |
Middle Eastern | 0.000381 | 0.000381 |
South Asian | 0.000201 | 0.000163 |
Other | 0.000176 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Required for MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) activation during gastrulation. Required for down- regulation of E-cadherin during gastrulation by regulating E- cadherin protein level downstream from NCK-interacting kinase (NIK) and independently of the regulation of transcription by FGF signaling and Snail (By similarity). Required for starvation- induced ATG9A trafficking during autophagy. {ECO:0000250, ECO:0000269|PubMed:19893488}.;
- Pathway
- Autophagy - animal - Homo sapiens (human);Chromatin modifying enzymes;HATs acetylate histones;Chromatin organization
(Consensus)
Recessive Scores
- pRec
- 0.123
Intolerance Scores
- loftool
- rvis_EVS
- -0.44
- rvis_percentile_EVS
- 24.46
Haploinsufficiency Scores
- pHI
- 0.513
- hipred
- Y
- hipred_score
- 0.552
- ghis
- 0.607
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- gene_indispensability_score
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Supt20
- Phenotype
- growth/size/body region phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); pigmentation phenotype; embryo phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;autophagy;gastrulation;positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter
- Cellular component
- SAGA complex;fibrillar center;SAGA-type complex
- Molecular function
- transcription coregulator activity;protein binding